Johnson & Johnson’s esketamine nasal spray continues to build a body of evidence showing it can go toe-to-toe with tough-to-treat depression. Wednesday, J&J’s Janssen unit rolled out data from the ...
December 7, 2009 — The US Food and Drug Administration (FDA) has approved a new indication for quetiapine fumarate extended-release tablets (Seroquel XR, AstraZeneca Pharmaceuticals, LP), allowing ...
LONDON, May 11 (Reuters) - AstraZeneca Plc hopes U.S. approval of a once-daily version of its blockbuster schizophrenia drug Seroquel, expected next week, can break a run of bad product news. The U.S.
LONDON, May 18 (Reuters) - Anglo-Swedish drugmaker AstraZeneca Plc said on Friday U.S. regulators had approved Seroquel XR, a once-daily version of its blockbuster schizophrenia drug. Seroquel is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results